Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

0
Player Avatar prcltrader (50.71) Submitted: 6/19/2009 11:41:21 AM : Outperform Start Price: $11.69 VNDA Score: -108.60

Aqcuisition or partnership

Featured Broker Partners


Advertisement